Portfolio company
Bitrobius Genetics
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops synthetic gene transfer technology for researchers and pharmaceutical firms to manufacture and deliver cell and gene therapies and vaccines.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Bitrobius
This company develops synthetic gene transfer technology to deliver DNA to cells for the treatment of genetic diseases and mitochondrial disorders.
Artis BioSolutions
The company produces synthetic DNA and manufacturing services for biotechnology and pharmaceutical firms developing genetic medicines and advanced therapies.
Gene Therapy Delivery Methods
This company develops viral and non-viral vector platforms to provide genetic material delivery solutions for biotechnology firms and healthcare providers.
Spot Biosystems
This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.
Anjarium BioSciences
This company develops non-viral gene therapies and synthetic DNA vectors for patients with genetic diseases and life sciences researchers.
Kytopen
This company develops non-viral gene delivery platforms for biotechnology researchers and pharmaceutical manufacturers to accelerate the production of gene-modified cell therapies.
Serotiny
This biotechnology company develops therapeutic multi-domain proteins for pharmaceutical and life sciences firms to enhance gene and cell therapies.
ZipBio
The company develops artificial intelligence to design gene therapies for pharmaceutical firms and biotechnology researchers.
